Dechra has licensed the long-term distribution rights for Zimeta® (dipyrone injection), which will further bolster Dechra’s equine product portfolio. Zimeta is the first and only FDA-approved drug for the control of pyrexia in horses.
SALT Chamber, the pioneer in providing halotherapy access to horses (equine salt therapy) and pets, has partnered with Eclipse Equine Sports Therapy Center to bring salt therapy to Santa Anita Park by designing and building a SALTainer™, which transforms shipping containers into transportable and permanent salt therapy concepts.
The “1st International PROfessional PFERD Congress on Equine Health” will take place Dec. 16-18, 2020 as part of the InterHorseFair.com
The first international, virtual specialist equine health congress offers three days of pure specialist knowledge.
To help veterinarians improve their ability to quickly and safely diagnose the cause of equine lameness, Hallmarq Veterinary Imaging announced its Standing Equine Leg CT, increasing access to advanced imaging for all veterinary practices.
Stall-side, reference-lab quality tests are now available for equine progesterone and foal IgG. Simple, cost-effective, and accurate tests by TargetVet produce numerical results in 10 minutes.
The app is designed to make the entire process, from listing a horse, to communicating between buyer and seller, to organizing shipping to a horse’s new home, as easy as a few taps of a button.
Gamble for Grayson Handicapping Challenge between Little Red Feather Racing and Equibase Company to benefit Grayson-Jockey Club Research Foundation
Grayson-Jockey Club Research Foundation announced today that it has partnered with Little Red Feather Racing and Equibase Company for the Gamble for Grayson Handicapping Challenge.
The app, called Cómo, connects Thoroughbred industry employees to the vital services they need through a network of chaplains and Thoroughbred industry organizations.
Adamis Pharmaceuticals Corporation has announced the signing of an agreement making it the sole US distributor of Arthramid® Vet, a patented polyacrylamide hydrogel (PAAG) for intra-articular injection – the first PAAG labeled for veterinary use for the management of non-infectious causes of joint disease in horses including both early and late stages of osteoarthritis and degenerative joint disease.
Including stories from his childhood and his career, Dr. Riddle recounts his role in establishing one of the largest equine veterinary practices in the world.